These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25446558)

  • 21. Minocycline restores spatial but not fear memory in olfactory bulbectomized rats.
    Borre Y; Sir V; de Kivit S; Westphal KG; Olivier B; Oosting RS
    Eur J Pharmacol; 2012 Dec; 697(1-3):59-64. PubMed ID: 23051675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects.
    Breuer ME; Chan JS; Oosting RS; Groenink L; Korte SM; Campbell U; Schreiber R; Hanania T; Snoeren EM; Waldinger M; Olivier B
    Eur Neuropsychopharmacol; 2008 Dec; 18(12):908-16. PubMed ID: 18789657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in emotional behavior of mice in the hole-board test after olfactory bulbectomy.
    Saitoh A; Hirose N; Yamada M; Yamada M; Nozaki C; Oka T; Kamei J
    J Pharmacol Sci; 2006 Dec; 102(4):377-86. PubMed ID: 17130673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute ghrelin administration reverses depressive-like behavior induced by bilateral olfactory bulbectomy in mice.
    Carlini VP; Machado DG; Buteler F; Ghersi M; Ponzio MF; Martini AC; Schiöth HB; de Cuneo MF; Rodrigues AL; de Barioglio SR
    Peptides; 2012 Jun; 35(2):160-5. PubMed ID: 22525660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnolol Enhances Hippocampal Neurogenesis and Exerts Antidepressant-Like Effects in Olfactory Bulbectomized Mice.
    Matsui N; Akae H; Hirashima N; Kido Y; Tanabe S; Koseki M; Fukuyama Y; Akagi M
    Phytother Res; 2016 Nov; 30(11):1856-1861. PubMed ID: 27510271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The olfactory bulbectomized rat model is not an appropriate model for studying depression based on morphological/stereological studies of the hippocampus.
    Yurttas C; Schmitz C; Turgut M; Strekalova T; Steinbusch HWM
    Brain Res Bull; 2017 Sep; 134():128-135. PubMed ID: 28734903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Panax quinquefolium involves nitric oxide pathway in olfactory bulbectomy rat model.
    Rinwa P; Kumar A
    Physiol Behav; 2014 Apr; 129():142-51. PubMed ID: 24582670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olfactory bulbectomy in mice triggers transient and long-lasting behavioral impairments and biochemical hippocampal disturbances.
    Almeida RF; Ganzella M; Machado DG; Loureiro SO; Leffa D; Quincozes-Santos A; Pettenuzzo LF; Duarte MMMF; Duarte T; Souza DO
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():1-11. PubMed ID: 28223107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guanosine fast onset antidepressant-like effects in the olfactory bulbectomy mice model.
    de Almeida RF; Pocharski CB; Rodrigues ALS; Elisabetsky E; Souza DO
    Sci Rep; 2020 May; 10(1):8429. PubMed ID: 32439951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. REM sleep deprivation reverses neurochemical and other depressive-like alterations induced by olfactory bulbectomy.
    Maturana MJ; Pudell C; Targa AD; Rodrigues LS; Noseda AC; Fortes MH; Dos Santos P; Da Cunha C; Zanata SM; Ferraz AC; Lima MM
    Mol Neurobiol; 2015 Feb; 51(1):349-60. PubMed ID: 24826915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An arginine vasopressin V1b antagonist, SSR149415 elicits antidepressant-like effects in an olfactory bulbectomy model.
    Iijima M; Chaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):622-7. PubMed ID: 17229509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.
    Sato H; Skelin I; Debonnel G; Diksic M
    Brain Res Bull; 2008 Mar; 75(5):545-55. PubMed ID: 18355630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential characteristics of ketamine self-administration in the olfactory bulbectomy model of depression in male rats.
    Babinska Z; Ruda-Kucerova J
    Exp Clin Psychopharmacol; 2017 Apr; 25(2):84-93. PubMed ID: 28301174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olfactory bulbectomy reduces cerebral glucose utilization: 2-[14C]deoxyglucose autoradiographic study.
    Skelin I; Sato H; Diksic M
    Brain Res Bull; 2008 Jul; 76(5):485-92. PubMed ID: 18534256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat.
    Morales-Medina JC; Dumont Y; Bonaventure P; Quirion R
    Neuropeptides; 2012 Dec; 46(6):329-34. PubMed ID: 23103057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new animal model for the prediction of antidepressant activity.
    Wren A; van Riezen H; Rigter H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):96-100. PubMed ID: 616925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Riluzole rapidly attenuates hyperemotional responses in olfactory bulbectomized rats, an animal model of depression.
    Takahashi K; Murasawa H; Yamaguchi K; Yamada M; Nakatani A; Yoshida M; Iwai T; Inagaki M; Yamada M; Saitoh A
    Behav Brain Res; 2011 Jan; 216(1):46-52. PubMed ID: 20620171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trans-species assessment of antidepressant activity in a rodent model of depression.
    Roche M; Shanahan E; Harkin A; Kelly JP
    Pharmacol Rep; 2008; 60(3):404-8. PubMed ID: 18622066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective and cognitive enhancing effects of a multi-targeted food intervention in an animal model of neurodegeneration and depression.
    Borre YE; Panagaki T; Koelink PJ; Morgan ME; Hendriksen H; Garssen J; Kraneveld AD; Olivier B; Oosting RS
    Neuropharmacology; 2014 Apr; 79():738-49. PubMed ID: 24286859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of exogenous and endogenous FGF-2 in animal models of depression.
    Jarosik J; Legutko B; Werner S; Unsicker K; von Bohlen Und Halbach O
    Restor Neurol Neurosci; 2011; 29(3):153-65. PubMed ID: 21586822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.